Cortexyme to present at the bofa securities 2020 health care conference on may 13, 2020

Cortexyme, inc. (nasdaq: crtx), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what it
QNCX Ratings Summary
QNCX Quant Ranking